DMII
insider transactionsDrugs Made In America Acquisition II Corp. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Cluster buy signal: Multiple insiders at the same company buying around the same time — often a stronger signal than a single buy. 2 different insiders made open-market purchases in the last 365 days.
Net shares · 365d
-13.1M
2.8M buy · 15.9M sell
Net value · 365d
$0
$0 in · $0 out
Sentiment · 365d
Net selling
0% buying · 0% selling
Open-market trades · 365d
6
2.8M buy · 15.9M sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Buy·P
Stockwell Lynn KEY
CEO and Exe. Chair of Board
—
700.0K sh
Own New
-
Other·J
Stockwell Lynn KEY
CEO and Exe. Chair of Board
—
400.0K sh
-
Sell·S
Stockwell Lynn KEY
CEO and Exe. Chair of Board
—
8.0M sh
Own -54%
-
Buy·P
Stockwell Lynn KEY
CEO and Exe. Chair of Board
—
700.0K sh
Own +5%
-
Other·J
Director
—
100.0K sh
-
Other·J
Worman Glenn C. KEY
CFO
—
100.0K sh
-
Buy·P
Drugs Made In America Acquisition II LLC
TenPercentOwner
—
700.0K sh
Own New
-
Sell·S
Drugs Made In America Acquisition II LLC
TenPercentOwner
—
8.0M sh
Own -54%
-
Other·J
Drugs Made In America Acquisition II LLC
TenPercentOwner
—
400.0K sh
-
Buy·P
Drugs Made In America Acquisition II LLC
TenPercentOwner
—
700.0K sh
Own +5%
-
Other·J
Director
—
100.0K sh
-
Other·J
Director
—
100.0K sh
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 26, 2025 | Stockwell Lynn KEY | Buy P | 700.0K | — |
| Sep 26, 2025 | Stockwell Lynn KEY | Other J | 400.0K | — |
| Sep 26, 2025 | Stockwell Lynn KEY | Sell S | 8.0M | — |
| Sep 26, 2025 | Stockwell Lynn KEY | Buy P | 700.0K | — |
| Sep 26, 2025 | Prasad Sridhar G. | Other J | 100.0K | — |
| Sep 26, 2025 | Worman Glenn C. KEY | Other J | 100.0K | — |
| Sep 26, 2025 | Drugs Made In America Acquisition II LLC | Buy P | 700.0K | — |
| Sep 26, 2025 | Drugs Made In America Acquisition II LLC | Sell S | 8.0M | — |
| Sep 26, 2025 | Drugs Made In America Acquisition II LLC | Other J | 400.0K | — |
| Sep 26, 2025 | Drugs Made In America Acquisition II LLC | Buy P | 700.0K | — |
| Sep 26, 2025 | Shulgan Myron W. | Other J | 100.0K | — |
| Sep 26, 2025 | Do Catherine | Other J | 100.0K | — |
About DMII insider trading
This page tracks insider transactions for Drugs Made In America Acquisition II Corp. (DMII) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.